Erythromycin Estolate from Japan
Erythromycin estolate is a lauryl sulfate ester salt derivative known for its acid stability in gastric environments for upper respiratory treatments. Falls under HTS 2941.50.00.00 as a named erythromycin derivative and salt per HTS antibiotic provisions. Bulk API form for tablet production.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Monitor for hepatotoxicity warnings in labeling; provide impurity profiles under ICH guidelines
• Pitfall: mislabeling as non-pharma chemical